Skip to content
User

Glenn W. Welling

Engaged Capital

Glenn W. Welling DexCom Inc stake

total: 101

Engaged Capital DXCM trades

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2017 Q3
Held for:
1 quarter
Latest activity:
2017 Q4
According to 2026 Q2 report, Glenn W. Welling doesn't hold any DexCom Inc (DXCM) shares. To date, the estimated cost basis is nearly $12.23 for "buy" trades and estimated average "sell" price is $12.23. Engaged Capital first purchased DXCM in 2017 Q3, initially acquiring 240,000 shares. Since the initial investment in DexCom Inc (DXCM), Engaged Capital has made 1 more transaction.

When did Glenn W. Welling sell DexCom Inc (DXCM)?

Glenn W. Welling sold off the entire DexCom Inc (DXCM) position in 2017 Q4.

When did Glenn W. Welling buy DexCom Inc (DXCM)?

Glenn W. Welling first invested in DexCom Inc (DXCM) in 2017 Q3 at the reported quarter-end price of $12.23 per share.

What's the cost basis of Engaged Capital's DXCM stake?

The estimated cost basis for DexCom Inc (DXCM) stake is around $12.23 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$12.23
Weighted AVG sell price:
$12.23

Glenn W. Welling's historical trades in DexCom Inc

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2017 Q4
0.00%
$12.23
-100% (-240,000)
2017 Q3
0.36%
$12.23
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.